Study on the Effect of Fibrin Matrice on the Antibacterial Activity of Clindamycin Phosphate

Scandinavian Society for Biomaterials (ScSB 2022) Conference 2022
Karina Egle, Lana Mičko, Andra Grava, Ilze Šalma, Ingus Skadiņš, Arita Dubņika

Platelet-rich fibrin (PRF) is an autologous material derived from a person’s own blood, which is used to promote wound healing and tissue regeneration. Clindamycin phosphate (CLP) is a semi-synthetic bacteriostatic lincomycin derivative with activity against anaerobic bacteria. Combination of PRF and CLP may enhance their antibacterial properties. The aim of this study was to investigate the effect of PRF on the antibacterial efficacy of clindamycin phosphate against Staphylococcus aureus and Staphylococcus epidermidis.

Keywords
antibacterial activity, clindamycin phosphate, platelet-rich fibrin
Hyperlink
https://ecmconferences.org/abstracts/2022/Collection2/Posters.pdf

Egle, K., Mičko, L., Grava, A., Šalma, I., Skadiņš, I., Dubņika, A. Study on the Effect of Fibrin Matrice on the Antibacterial Activity of Clindamycin Phosphate. In: Scandinavian Society for Biomaterials (ScSB 2022) Conference, Latvia, Jurmala, 13-15 June, 2022. Riga: 2022, pp.P19-P19.

Publication language
English (en)